Logo-bma
Biomed adv. 2025;2(3): 131-136. doi: 10.34172/bma.26

Review Article

New developments in epigenetic and genetic biomarkers for differentiated thyroid cancer (DTC): Moving toward accurate diagnosis and treatment by 2025

Samaneh Hosseinzadeh ORCID, Safura Pakizehkar, Hoda Golab-Ghadaksaz, Laleh Hoghooghi Rad, Mehdi Hedayati * ORCID

Cited by CrossRef: 0



Acceptance Rate: 35%
Submission to First Decision: 20 Days
Received to Acceptance: 60 Days
Acceptance to Publication: 40 Days
*Average article statistics from the last 12 months of data.